Acquisition of Amikacin Resistance during Amikacin Liposome Inhalation Suspension Add-on Therapy for Mycobacterium avium Complex Pulmonary Disease

被引：0
|
作者：
Sano, Hirohito [1 ]
Fujino, Naoya [1 ]
Numakura, Tadahisa [1 ]
Yamada, Mitsuhiro [1 ]
Tode, Naoki [1 ]
Sugiura, Hisatoshi [1 ]
机构：
[1] Tohoku Univ, Grad Sch Med, Sendai, Miyagi, Japan
来源：
ANNALS OF THE AMERICAN THORACIC SOCIETY | 2024年 / 21卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：526 / 529
页数：4
相关论文
共 50 条
  • [41] INTRACELLULAR KILLING OF MYCOBACTERIUM-AVIUM COMPLEX BY RIFAPENTINE AND LIPOSOME-ENCAPSULATED AMIKACIN
    BERMUDEZ, LEM
    WU, M
    YOUNG, LS
    JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (03): : 510 - 513
  • [42] ALIS (Amikacin Liposome Inhalation Suspension) for the Treatment of Patients with Refractory Mycobacterium avium Complex Lung Disease (MACLD) the Number Needed to Treat (NNT) and Number Needed to Harm (NNH)
    Marras, T. K.
    Hassan, M.
    Mange, K. C.
    Ciesielska, M.
    Sonnenahalli, S. Dhar
    Jumadilova, Z.
    Chatterjee, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [43] The treatment outcomes of cavitary Mycobacterium avium complex pulmonary disease according to the use of amikacin or streptomycin
    Kim, Seong Min
    Shim, Tae Sun
    Jo, Kyung-Wook
    RESPIROLOGY, 2023, 28 : 204 - 204
  • [44] Challenges in achieving the guideline-recommended amikacin level for Mycobacterium avium complex pulmonary disease
    Akutsu, Takuya
    Tone, Kazuya
    Hasegawa, Airi
    Kitayama, Takaaki
    Inaki, Shunsuke
    Gochi, Mina
    Takagi, Masamichi
    Araya, Jun
    JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2025, 39
  • [45] Comparison of Treatment Outcomes of Cavitary Mycobacterium avium Complex Pulmonary Disease with Streptomycin or Amikacin Use
    Kim, Seong Min
    Chong, Yong Pil
    Lee, Hyun Joo
    Shim, Tae Sun
    Jo, Kyung-Wook
    MICROBIOLOGY SPECTRUM, 2023, 11 (03)
  • [46] Evaluation of Antimicrobial Susceptibility to Amikacin Liposome Inhalation Suspension and Relapse/Reinfection in Pulmonary M. Abscessus Disease
    Siegel, S. A.
    Brown-Elliott, B. A.
    Strnad, L. C.
    Fuss, C.
    Griffith, D. E.
    Wallace, R. J., Jr.
    Philley, J. V.
    Winthrop, K. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [47] Randomized Phase 3 Trial of Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC) in Adult Patients
    Griffith, D. E.
    Eagle, G.
    Thomson, R. M.
    Aksamit, T. R.
    Hasegawa, N.
    Morimoto, K.
    Addrizzo-Harris, D. J.
    O'Donnell, A. E.
    Marras, T. K.
    Flume, P. A.
    Loebinger, M. R.
    Morgan, L. C.
    Castellotti, P. F.
    Hill, A. T.
    Ruoss, S. J.
    Yim, J. J.
    Ringshausen, F. C.
    Field, S. K.
    Nezamis, J.
    Winthrop, K. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [48] Sustainability and Durability of Culture Conversion in Patients Receiving Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Mycobacterium Avium Complex Lung Disease (MAC-LD) in the CONVERT Study
    Griffith, D. E.
    Thomson, R.
    Addrizzo-Harris, D. J.
    Field, S. K.
    van Ingen, J.
    Wallace, R. J., Jr.
    Coulter, C.
    Mange, K.
    Nezamis, J.
    Winthrop, K. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [49] AMIKACIN-INDUCED HYPERSENSITIVITY PNEUMONITIS IN A PATIENT WITH PULMONARY MYCOBACTERIUM AVIUM COMPLEX INFECTION
    Graziani, Casey
    Jiwani, Ali
    CHEST, 2021, 160 (04) : 1166A - 1166A
  • [50] Assessing Primary and Secondary Resistance to Clarithromycin and Amikacin in Infections Due to Mycobacterium avium Complex
    Renvoise, Aurelie
    Brossier, Florence
    Galati, Eve
    Veziris, Nicolas
    Sougakoff, Wladimir
    Aubry, Alexandra
    Robert, Jerome
    Cambau, Emmanuelle
    Jarlier, Vincent
    Bernard, Christine
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (11) : 7153 - 7155
12345